Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helen Heathcote

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
The Veterinary Record|July 25, 2006
Internet access overseasGerri McHugh, Helen Heathcote
Molecular Pharmacology|August 28, 2013
The pharmacology of TUG-891, a potent and selective agonist of the free fatty acid receptor 4 (FFA4/GPR120), demonstrates both potential opportunity and possible challenges to therapeutic agonismBrian D Hudson, Bharat Shimpukade, Amanda E Mackenzie, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
The Veterinary Record|July 25, 2006
Internet access overseasGerri McHugh, Helen Heathcote
Molecular Pharmacology|August 28, 2013
The pharmacology of TUG-891, a potent and selective agonist of the free fatty acid receptor 4 (FFA4/GPR120), demonstrates both potential opportunity and possible challenges to therapeutic agonismBrian D Hudson, Bharat Shimpukade, Amanda E Mackenzie, et al.
Pageof 1